title: Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment.
authors.forename: Ryoko
authors.initials: R
authors.lastname: Horikoshi
authors.forename: Tetsu
authors.initials: T
authors.lastname: Akimoto
authors.forename: Makoto
authors.initials: M
authors.lastname: Inoue
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Morishita
authors.forename: Eiji
authors.initials: E
authors.lastname: Kusano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D016903:Drug Monitoring; D000069465:Febuxostat; D006074:Gout Suppressants / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D033461:Hyperuricemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013844:Thiazoles / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood
chemical_list: D015415:Biomarkers; D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D014527:Uric Acid